ClinicalTrials.gg
Not yet recruitingNCT07588815Updated May 15, 2026

Acupuncture Treament in Children With Tic Disorders

An interventional study of Acupuncture and Comprehensive Behavioral Intervention for Tics (CBIT) in Tic Disorder, Childhood, sponsored by Meizhou People's Hospital. Not yet recruiting. Open to participants aged 5 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Meizhou People's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

This study intends to evaluate the efficacy of acupuncture on tic disorders in Children; and to explore the underlying mechanism of acupuncture intervention on tic disorders based on Magnetic Resonance Diffusion Tensor Imaging(MR-DTI).

02

Conditions studied

  • Tic Disorder, Childhood

Browse trials for

Keywords

  • Tic disorers
  • Acupuncture
  • Magnetic Resonance Diffusion Tensor Imaging
03

In context

Tic Disorders

102 studies on the registry are indexed under Tic Disorders; 26 are open to participants now.

This study's planned enrollment of 102 is above the median of 50 across 83 interventional studies indexed under Tic Disorders.

Browse Tic Disorders studies →

Lead sponsor

This is the only study on the registry with Meizhou People's Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must meet the diagnostic criteria for Provisional Tic Disorder (PTD) or Persistent (Chronic) Motor or Vocal Tic Disorder (CTD)
  • Right-handed children aged 5-18 years
  • Have not previously received systematic acupuncture treatment and are able to adhere to acupuncture treatment for ≥ 2 months
  • Complete medical records available
  • Not currently participating in any other clinical study
  • Voluntary participants, with the signature and consent of their guardians, and children aged 8 and above obtaining their own

Exclusion criteria

Exclusion Criteria:

  • History of hepatolenticular degeneration (Wilson's disease), rheumatic chorea, childhood migraine, epilepsy, intellectual disability, schizophrenia, or other related conditions
  • Presence of organic neurological diseases or other severe conditions significantly impacting quality of life
  • Recent use of centrally-acting medications
  • Inability to regularly complete the acupuncture treatment regimen
  • Inability to undergo the MR-DTI examination
  • Refusal to sign the written form
  • Inability of the child or guardian to cooperate during the treatment and follow-up process
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
102 participants (estimated)

Study arms

  • Experimental
    Acupuncture group

    Behavioral intervention and acupuncture

    Other: Acupuncture · Behavioral: Comprehensive Behavioral Intervention for Tics (CBIT)

  • Other
    Waiting for acupuncture group

    Behavioral intervention

    Behavioral: Comprehensive Behavioral Intervention for Tics (CBIT)

  • No intervention
    Healthy control group

    Healthy participants without intervention

Interventions

  • OtherAcupuncture

    The Acupuncture point prescription is as follows: Sishencong (EX-HN1), bilateral Shuaigu (GB8), bilateral Yangbai (GB14), bilateral Sibai (ST2), bilateral Fengchi (GB20), bilateral Fenglong (ST40), bilateral Hegu (LI4), and bilateral Taichong (LR3). Points will be selected based on Traditional Chinese Medicine syndrome differentiation, with location standardized according to the 2006 National Standard of the People's Republic of China (GB/T 12346-2006), "Nomenclature and Location of Acupuncture Points." After routine skin disinfection, Sishencong will be obliquely needled to a depth of 0.5 cun, and the remaining points will be perpendicularly needled to a depth of 1 cun. The twirling manipulation will be applied until the needling sensation (Deqi) is locally achieved. Needles will be retained for 30 minutes. Treatment will be administered once daily, 5 times per week, for a total of 8 weeks (40 sessions).

  • BehavioralComprehensive Behavioral Intervention for Tics (CBIT)

    Comprehensive Behavioral Intervention for Tics (CBIT) is recommended as a first-line intervention by organizations such as the American Academy of Neurology.It consists of several core components: Psychoeducation,Awareness Training,Competing Response Training,Function-Based Intervention and Social Support and Relapse Prevention

06

What researchers measure

Primary outcomes

  1. Yale Global Tic Severity Scal(YGTSS)

    The Yale Global Tic Severity Scale (YGTSS) Score is designed to assess the severity of symptoms in children with TD by scoring the type of tics, frequency of tics, intensity of tics, complexity of tics, degree of interference with normal behavior, and degree of impairment of social functioning in the child, with a total score ranging from 0-75, with higher scores indicating greater severity of the child's condition.

    Time frame: baseline,4 weeks,8 weeks,6 months

  2. MR-DTI

    Magnetic Resonance Diffusion Tensor Imaging(MR-DTI).Scanning will employ a single-shot echo-planar imaging sequence with 15 diffusion gradient directions. Software such as DTI Studio will be used to calculate the Mean Diffusivity (MD), Fractional Anisotropy (FA), and Apparent Diffusion Coefficient (ADC) values for each subject's corpus callosum, bilateral globus pallidus, thalamus, putamen, and caudate nucleus.

    Time frame: baseline,8 weeks

Secondary outcomes

  1. Pediatric quality of life inventory

    Pediatric quality of life inventory 4.0(PedsQL 4.0) is composed of 23 items comprising 4 dimensions: : 1) Physical Functioning (8 items), 2) Emotional Functioning (5 items), 3) Social Functioning (5 items), and 4) School Functioning (5 items). Higher scores indicate better HRQOL with a range of 0-100.

    Time frame: baseline,4 weeks,8 weeks,6 months

  2. Traditional Chinese Medicine Symptom Score

    Traditional Chinese medicine symptom score is used to assess overall health status, including aspects such as mood, appearance, sleep, diet, and gastrointestinal function. Higher scores indicate more severe symptoms with a range of 0-100.

    Time frame: baseline,4 weeks,8 weeks,6 months

Other outcomes

  1. Acupuncture-Related Adverse Events

    All adverse events occurring during the intervention will be recorded

    Time frame: 8 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for May 2029, 35 months later.

Of 39 non-industry interventional studies with no phase under Tic Disorders, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 64. This study's planned 35 months is above that.

Counting every sponsor, half of 39 studies reached it within 28 months; a quarter within 16 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2026
First posted
May 15, 2026
StartEst.
Jun 2026
Primary completionEst.
May 2029
CompletionEst.
May 2030
Last update
May 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07588815
Lead sponsor
Meizhou People's Hospital
Responsible party
Sponsor
First posted
May 15, 2026
Start date
Jun 2026 (estimated)
Primary completion
May 2029 (estimated)
Completion
May 2030 (estimated)
Last update
May 15, 2026

Study contacts

Zhongtao Song, PhD
Contact
songzhongtao1@mzrmyy.com
0086-19820151649

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion